Free Trial

HLS Therapeutics (TSE:HLS) Shares Down 1.2% - What's Next?

HLS Therapeutics logo with Medical background

HLS Therapeutics Inc. (TSE:HLS - Get Free Report)'s stock price traded down 1.2% during trading on Wednesday . The stock traded as low as C$4.15 and last traded at C$4.15. 7,598 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 20,668 shares. The stock had previously closed at C$4.20.

Analyst Ratings Changes

Separately, Raymond James boosted their target price on shares of HLS Therapeutics from C$4.00 to C$5.00 in a research report on Friday, November 22nd.

View Our Latest Stock Report on HLS

HLS Therapeutics Stock Performance

The stock's 50 day moving average price is C$4.00 and its 200 day moving average price is C$3.63. The company has a debt-to-equity ratio of 86.50, a quick ratio of 1.01 and a current ratio of 1.56. The company has a market capitalization of C$92.77 million, a P/E ratio of -4.18 and a beta of 1.07.

HLS Therapeutics Company Profile

(Get Free Report)

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.

Featured Articles

Should You Invest $1,000 in HLS Therapeutics Right Now?

Before you consider HLS Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HLS Therapeutics wasn't on the list.

While HLS Therapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines